Le Lézard

Communiqués de presse par sujet : Santé

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

14:03
As part of our Global Commitment to continue leading our industry to operate more sustainably, this Earth Day, we at Global Container Terminals (GCT) have much to celebrate. Demonstrating our responsible stewardship, our Canadian and US operations...


19 avril 2018

08:03
CTD Holdings, Inc. , a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has finalized a cooperative research agreement with Kerwin...


18 avril 2018

16:33
Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to restore innate immune function, is pleased to announce the receipt of a ?No...

08:03
With April being Alcohol Awareness Month, studies show 83% of Canadians who drink excessively received no advice or encouragement from family and friends to cut down their drinking.   Women with drinking problems were much less likely than men to...

07:03
- Preclinical models proved pelareorep increased PD-L1 expression in microsatellite stable (MSS) colorectal cancer cells (CRC) -- Demonstrated efficacy of pelareorep and anti-PD1 agent combination -Oncolytics Biotech® Inc. , currently developing...

07:03
Trillium Therapeutics Inc. , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that preclinical data from its TTI-622 (SIRPa-IgG4 Fc) immune checkpoint inhibitor program were...


17 avril 2018

10:03
The Health Quality Council of Alberta (HQCA) today released results of a 2017 survey of family experiences with long-term care facilities across Alberta. The Long-term Care Family Experience Survey, completed by the HQCA four times over the last 10...

08:03
VBI Vaccines Inc. ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that, upon review of all safety data from the fully...


16 avril 2018

08:03
Titan Medical Inc. ("Titan" or the "Company") , a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces the presentation of an...

07:03
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the outcome of its end-of-review meeting with the U.S. Food and Drug Administration (FDA) on the New Drug Application...


13 avril 2018

13:33
On this week's swing through Northwestern Ontario PC Party Leader Doug Ford cited wildly incorrect numbers for hospital bed costs and raised the spectre of another round of hospital bed cuts. Mr. Ford was quoted in Thunder Bay's media yesterday...

08:03
Dr. Rafi Hofstein, President and CEO of MaRS Innovation (MI) announced today that as part of Toronto Health Innovation Week, MI will lead a special health innovation and investment mission to Seoul, South Korea from May 9 to May 11, 2018....


10 avril 2018

08:03
Wave Life Sciences Ltd. , a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, and Deep Genomics Inc., a biotechnology company that is building a new universe of genetic...

07:33
Helix BioPharma Corp. ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that all necessary regulatory and ethics approvals have...

07:03
Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company's lead, oral Selective Inhibitor of Nuclear Export (SINE)...

07:03
Trillium Therapeutics Inc. , a clinical stage immuno-oncology company developing innovative...


9 avril 2018

08:03
Pfizer Canada est fière d'annoncer qu'elle fera une contribution de 800 000 $ pour appuyer la vision et la mission de MaRS Innovation. Cet investissement permettra de financer de nouvelles idées et technologies dans le domaine des sciences de la...

08:03
Pfizer Canada is proud to announce an $800,000 contribution to MaRS Innovation to support the vision and mission of MaRS Innovation by providing funding for new ideas or technologies in the health sciences including; therapeutics, diagnostic and...


5 avril 2018

11:03
Specialist insurance buyers for major hospital systems, long-term care facilities, physicians groups, and health benefits and services providers in North America come to the island this month for the second Bermuda Healthcare Forum. A total of 206...

08:03
VistaGen Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) disorders, today announced the initiation of ELEVATE, the Company's double-blind,...


4 avril 2018

14:33
Adam Vaughan, Parliamentary Secretary to the Minister of Families, Children and Social Development makes a crime prevention funding announcement to Child Development Institute's SNAP® evidence-based mental health program on behalf of the Honourable...

12:03
In the face of quickly rising global obesity and diabetes rates, there is a high-stakes and high-tech race to find new and better ways to reduce and replace sucrose across the food and beverage industry. To identify which sugar reduction technologies...

10:33
Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that it has received approval of a...

08:33
Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of...

06:33
Education Arts Canada (EAC) is in high demand with its popular musical hit, The Secret Life of Riley K, experiencing an unprecedented run touring to schools in York Region, Simcoe County and beyond. This engaging play is geared for students in Grades...


3 avril 2018

08:03
3D Signa­­­­­­tures Inc. (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of chromosomal signatures, is pleased to announce the successful and...


29 mars 2018

14:03
CTD Holdings, Inc. , a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has completed an initial review of safety data for its...


28 mars 2018

18:03
Arbutus Biopharma Corporation , an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced presentation of data at the 53rd Annual International Liver Congress of the European Association for the Study of the Liver...

17:33
Emerging from the budget lock up this afternoon, Ontario Health Coalition spokespeople were positive but cautious about the health care funding announcements.                   Overall, the budget plans a one-year bump up in funding and several...

07:33
ICC Labs Inc. ("ICC Labs" or the...


27 mars 2018

15:03
Talk about a national contribution: a kind donation of cable and satellite air time from Shaw Communications is allowing many returned veterans a second chance at life. The air time was much needed to create awareness for the Veterans Transition...

11:33
Canadians with chronic conditions are experiencing medication errors and undergoing unnecessary repeat procedures according to a national survey commissioned by Orion Health. The Orion Health Chronic Care Index, a Leger poll* of 1,551 residents...

08:33
Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of...

06:33
Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted PEDMARKtm (a unique formulation of sodium thiosulfate) Breakthrough Therapy designation for prevention of...


26 mars 2018

10:33
Advanzeon Solutions, Inc. ("Advanzeon") announced today that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") has entered into an Agreement with T A Baxter, LLC ("Baxter"), a specialty pharmaceutical company...

07:03
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that its end-of-review meeting with the U.S. Food and Drug Administration ("FDA") to discuss the New Drug Application...

06:33
Avivagen Inc. ("Avivagen" or the "Corporation"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general...


24 mars 2018

09:04
GENÈVE, Suisse, 23 mars 2018 - Genomic Health annonce aujourd’hui la présentation de nouvelles données concernant le test Oncotype DX® lors de la 11ème édition de l’"European Breast Cancer...


23 mars 2018

14:03
At an Official Inauguration Ceremony held today at the University of Ottawa Heart Institute, Dr. Thierry Mesana, President and CEO, joined Yasir Naqvi, Ontario's Attorney General and MPP for Ottawa Centre, Bob Chiarelli, Minister of Infrastructure...

14:03
Aujourd'hui, dans le cadre de la cérémonie d'inauguration officielle du nouvel édifice de l'Institut de cardiologie de l'Université d'Ottawa, le Dr Thierry Mesana, président-directeur général de l'Institut de cardiologie de l'Université d'Ottawa,...


21 mars 2018

16:23
NanoVibronix Inc. , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher Mariano Rivera were...

06:33
Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted PEDMARK (a unique formulation of sodium thiosulfate) Fast Track designation for prevention of...


20 mars 2018

11:33
"Public dental care to cover everyone is welcome news from NDP Leader Andrea Horwath," says Natalie Mehra, Executive Director of the Ontario Health Coalition. "We stand in full support of public dental care. ...

09:03
L'Institut de cardiologie de l'Université d'Ottawa invite les médias, le jeudi 22 mars, pour une visite préparatoire exclusive de ses nouvelles installations ultramodernes de soins cardiovasculaires, les plus sophistiquées au Canada! La cérémonie...

09:03
Members of the media are invited to visit the University of Ottawa Heart Institute on Thursday, March 22 for an exclusive sneak peek and guided tour inside the hospital's brand new, ultramodern cardiovascular facility ? the latest and most...

07:03
Oncolytics Biotech® Inc. , a biotech company developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype, today announced that Grey Wilkinson, Ph.D., scientist of Translational Medicine at...


19 mars 2018

08:33
Viveve Medical, Inc. , a medical technology company focused on women's intimate health, today announced it received approval of its Investigational Device Exemption (IDE) application from the U.S. Food and Drug Administration (FDA). The approval...

07:03
On Tuesday, March 20, the Fraser Institute will release a new study on health care. How Canadian Health Care Differs from Other Systems compares health-care policy in Canada with other universal health-care countries, highlighting the different...

07:03
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has successfully surpassed the planned enrollment target of over 2,400 patients in the ongoing Phase 3 BETonMACE trial. The trial's first patient was enrolled on November...

06:33
Thérapeutique Knight inc. («?Knight?»), a annoncé aujourd'hui une entente de licence avec Ardelyx, Inc. («?Ardelyx?») qui procure à Knight les droits exclusifs de commercialisation de tenapanor au Canada. Tenapanor, une petite molécule, est un...

1 2 3 4 5 6 7 8 9 10